Feng Z - Search Results

1

Metastatic patterns do not provide additional prognostic information for patients with FIGO stage IV high-grade serous ovarian cancer.

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X. Feng Z, et al. J Surg Oncol. 2020 Aug;122(2):315-319. doi: 10.1002/jso.25941. Epub 2020 Jun 4. J Surg Oncol. 2020. PMID: 32500598

2

Thrombocytosis and hyperfibrinogenemia are predictive factors of clinical outcomes in high-grade serous ovarian cancer patients.

Feng Z, Wen H, Bi R, Duan Y, Yang W, Wu X. Feng Z, et al. BMC Cancer. 2016 Jan 27;16:43. doi: 10.1186/s12885-016-2070-2. BMC Cancer. 2016. PMID: 26817451 Free PMC article.

3

Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.

Bi R, Shen X, Zhang W, Cheng Y, Feng Z, Cai X, Yang W. Bi R, et al. Among authors: feng z. Diagn Pathol. 2016 Feb 2;11:17. doi: 10.1186/s13000-016-0467-5. Diagn Pathol. 2016. PMID: 26837693 Free PMC article.

4

Prognostic impact of the time interval from primary surgery to intravenous chemotherapy in high grade serous ovarian cancer.

Feng Z, Wen H, Bi R, Yang W, Wu X. Feng Z, et al. Gynecol Oncol. 2016 Jun;141(3):466-470. doi: 10.1016/j.ygyno.2016.04.016. Epub 2016 Apr 23. Gynecol Oncol. 2016. PMID: 27098361

5

A clinically applicable molecular classification for high-grade serous ovarian cancer based on hormone receptor expression.

Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W, Wu X. Feng Z, et al. Sci Rep. 2016 May 3;6:25408. doi: 10.1038/srep25408. Sci Rep. 2016. PMID: 27139372 Free PMC article.

6

Preoperative Neutrophil-to-Lymphocyte Ratio as a Predictive and Prognostic Factor for High-Grade Serous Ovarian Cancer.

Feng Z, Wen H, Bi R, Ju X, Chen X, Yang W, Wu X. Feng Z, et al. PLoS One. 2016 May 20;11(5):e0156101. doi: 10.1371/journal.pone.0156101. eCollection 2016. PLoS One. 2016. PMID: 27203425 Free PMC article.

7

Expression of hypothalamic-pituitary-gonadal axis-related hormone receptors in low-grade serous ovarian cancer (LGSC).

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X. Feng Z, et al. J Ovarian Res. 2017 Jan 25;10(1):7. doi: 10.1186/s13048-016-0300-5. J Ovarian Res. 2017. PMID: 28122595 Free PMC article.

8

Hormone receptor expression profiles differ between primary and recurrent high-grade serous ovarian cancers.

Feng Z, Wen H, Ju X, Bi R, Chen X, Yang W, Wu X. Feng Z, et al. Oncotarget. 2017 May 16;8(20):32848-32855. doi: 10.18632/oncotarget.15858. Oncotarget. 2017. PMID: 28416763 Free PMC article.

9

Tumor-to-background ratios of the maximum standardized uptake value could not indicate the prognosis of advanced high-grade serous ovarian cancer patients.

Liu S, Ju X, Feng Z, Wen H, Xu J, Chen X, Wu X. Liu S, et al. Among authors: feng z. Nucl Med Commun. 2018 Apr;39(4):319-324. doi: 10.1097/MNM.0000000000000798. Nucl Med Commun. 2018. PMID: 29533344

10

Prognostic predictive value of preoperative intratumoral 2-deoxy-2-(18F)fluoro-D-glucose uptake heterogeneity in patients with high-grade serous ovarian cancer.

Liu S, Feng Z, Jiang Z, Wen H, Xu J, Pan H, Deng Y, Zhang L, Ju X, Chen X, Wu X. Liu S, et al. Among authors: feng z. Nucl Med Commun. 2018 Oct;39(10):928-935. doi: 10.1097/MNM.0000000000000861. Nucl Med Commun. 2018. PMID: 29771717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,182 results

Search Page

Filters